MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Levocabastine.
Acepromazine
The risk or severity of adverse effects can be increased when Acepromazine is combined with Levocabastine.
Aceprometazine
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Levocabastine.
Alfaxalone
The risk or severity of adverse effects can be increased when Alfaxalone is combined with Levocabastine.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Levocabastine.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Levocabastine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Levocabastine.
Amisulpride
The risk or severity of adverse effects can be increased when Amisulpride is combined with Levocabastine.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocabastine.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Levocabastine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Levocabastine.
Amphetamine
Amphetamine may decrease the sedative activities of Levocabastine.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Levocabastine.
Articaine
The risk or severity of adverse effects can be increased when Articaine is combined with Levocabastine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Levocabastine.
Azelastine
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Levocabastine.
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Levocabastine.
Benoxinate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levocabastine.
Benperidol
The risk or severity of adverse effects can be increased when Benperidol is combined with Levocabastine.
Benzocaine
The risk or severity of adverse effects can be increased when Benzocaine is combined with Levocabastine.
Benzphetamine
Benzphetamine may decrease the sedative activities of Levocabastine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Levocabastine.
Benzylpenicilloyl polylysine
Levocabastine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocabastine.
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Levocabastine.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Levocabastine.
Bromperidol
The risk or severity of adverse effects can be increased when Bromperidol is combined with Levocabastine.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Levocabastine.
Brotizolam
The risk or severity of adverse effects can be increased when Brotizolam is combined with Levocabastine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Levocabastine.
Buprenorphine
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Levocabastine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Levocabastine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Levocabastine.
Butamben
The risk or severity of adverse effects can be increased when Butamben is combined with Levocabastine.
Butobarbital
The risk or severity of adverse effects can be increased when Butethal is combined with Levocabastine.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levocabastine.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levocabastine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Levocabastine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Levocabastine.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Levocabastine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Levocabastine.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Levocabastine.
Chlormethiazole
The risk or severity of adverse effects can be increased when clomethiazole is combined with Levocabastine.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Levocabastine.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Levocabastine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levocabastine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Levocabastine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Levocabastine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Levocabastine.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Levocabastine.
Citalopram
The risk or severity of adverse effects can be increased when Levocabastine is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Levocabastine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Levocabastine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Levocabastine.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Levocabastine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Levocabastine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Levocabastine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Levocabastine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Levocabastine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Levocabastine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Levocabastine.
Cocaine
The risk or severity of adverse effects can be increased when Cocaine is combined with Levocabastine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Levocabastine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Levocabastine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Levocabastine.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Levocabastine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Levocabastine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Levocabastine.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Levocabastine.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Levocabastine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Levocabastine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Levocabastine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Levocabastine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levocabastine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Levocabastine.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Levocabastine.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Levocabastine.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Levocabastine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Levocabastine.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Levocabastine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Levocabastine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Levocabastine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Levocabastine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Levocabastine.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Levocabastine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Levocabastine.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Levocabastine.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Duloxetine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Levocabastine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Levocabastine.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Levocabastine.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Levocabastine.
Escitalopram
The risk or severity of adverse effects can be increased when Levocabastine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Levocabastine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levocabastine.
Ethanol
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Levocabastine.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Levocabastine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Levocabastine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Ethyl chloride is combined with Levocabastine.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Levocabastine.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Levocabastine.
Etidocaine
The risk or severity of adverse effects can be increased when Etidocaine is combined with Levocabastine.
Etifoxine
The risk or severity of adverse effects can be increased when Etifoxine is combined with Levocabastine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Levocabastine.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Levocabastine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Levocabastine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Levocabastine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Levocabastine.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Levocabastine.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levocabastine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Levocabastine.
Fluoxetine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Levocabastine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levocabastine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Levocabastine.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Levocabastine.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Levocabastine.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Levocabastine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Levocabastine.
Fospropofol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Levocabastine.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Levocabastine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Levocabastine.
Glutethimide
The risk or severity of adverse effects can be increased when Glutethimide is combined with Levocabastine.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Levocabastine.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Levocabastine.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Levocabastine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Levocabastine.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Levocabastine.
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Levocabastine.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Levocabastine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Levocabastine.
Hydrocodone
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levocabastine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Levocabastine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Levocabastine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Levocabastine.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Levocabastine.
Ketazolam
The risk or severity of adverse effects can be increased when Ketazolam is combined with Levocabastine.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Levocabastine.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Levocabastine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Levocabastine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Levocabastine.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Levocabastine.
Levomilnacipran
The risk or severity of adverse effects can be increased when Levocabastine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Levocabastine.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Levocabastine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Levocabastine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Levocabastine.
Lithium
The risk or severity of adverse effects can be increased when Lithium is combined with Levocabastine.
Lithium Cation
The risk or severity of adverse effects can be increased when Lithium is combined with Levocabastine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Levocabastine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Levocabastine.
Lormetazepam
The risk or severity of adverse effects can be increased when Lormetazepam is combined with Levocabastine.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Levocabastine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Levocabastine.
Magnesium Sulfate
The therapeutic efficacy of Levocabastine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Levocabastine can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Levocabastine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Levocabastine.
Melatonin
The risk or severity of adverse effects can be increased when Melatonin is combined with Levocabastine.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Levocabastine.
Mephentermine
Mephentermine may decrease the sedative activities of Levocabastine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Levocabastine.
Mepivacaine
The risk or severity of adverse effects can be increased when Mepivacaine is combined with Levocabastine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Levocabastine.
Mesoridazine
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Levocabastine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levocabastine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Levocabastine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Levocabastine.
Methamphetamine
Methamphetamine may decrease the sedative activities of Levocabastine.
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Levocabastine.
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Levocabastine.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Levocabastine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Levocabastine.
Methotrimeprazine
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Levocabastine.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Levocabastine.
Metylperon
The risk or severity of adverse effects can be increased when Melperone is combined with Levocabastine.
Metyrosine
Levocabastine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Levocabastine.
Milnacipran
The risk or severity of adverse effects can be increased when Levocabastine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Mirtazapine
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Molindone is combined with Levocabastine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Levocabastine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Levocabastine.
Nefazodone
The risk or severity of adverse effects can be increased when Levocabastine is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Levocabastine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Levocabastine.
Norflurane
The risk or severity of adverse effects can be increased when Norflurane is combined with Levocabastine.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Levocabastine.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Levocabastine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Levocabastine.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Levocabastine.
Ondansetron
The risk or severity of adverse effects can be increased when Ondansetron is combined with Levocabastine.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Levocabastine.
Orphenadrine
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Levocabastine.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Levocabastine.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Levocabastine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Levocabastine.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Levocabastine.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Levocabastine.
Paraldehyde
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Levocabastine.
Paroxetine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Levocabastine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Levocabastine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Perazine
The risk or severity of adverse effects can be increased when Perazine is combined with Levocabastine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Levocabastine.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Levocabastine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Levocabastine.
Phentermine
Phentermine may decrease the sedative activities of Levocabastine.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Levocabastine.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Levocabastine.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Levocabastine.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Levocabastine.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Levocabastine.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Levocabastine.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Levocabastine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Levocabastine.
Pramipexole
Levocabastine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Pramocaine is combined with Levocabastine.
Prazepam
The risk or severity of adverse effects can be increased when Prazepam is combined with Levocabastine.
Pregabalin
The therapeutic efficacy of Levocabastine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Levocabastine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Levocabastine.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Levocabastine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Levocabastine.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Levocabastine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Levocabastine.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Levocabastine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Levocabastine.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Levocabastine.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levocabastine.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Levocabastine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Levocabastine.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Levocabastine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Levocabastine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Levocabastine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levocabastine.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Levocabastine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Levocabastine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Levocabastine.
Ropinirole
Levocabastine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levocabastine.
Rotigotine
Levocabastine may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Levocabastine.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Levocabastine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Levocabastine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Levocabastine.
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Levocabastine.
Sertraline
The risk or severity of adverse effects can be increased when Levocabastine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Levocabastine.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Levocabastine.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Levocabastine.
Suvorexant
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Levocabastine.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Levocabastine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Levocabastine.
Tetracaine
The risk or severity of adverse effects can be increased when Tetracaine is combined with Levocabastine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Tetracaine is combined with Levocabastine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Thalidomide
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Levocabastine.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Levocabastine.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Levocabastine.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Levocabastine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Levocabastine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Levocabastine.
Tiapride
The risk or severity of adverse effects can be increased when Tiapride is combined with Levocabastine.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Levocabastine.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Levocabastine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Levocabastine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Levocabastine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Levocabastine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Levocabastine.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Levocabastine.
Triazulenone
The risk or severity of adverse effects can be increased when Loprazolam is combined with Levocabastine.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levocabastine.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Levocabastine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Levocabastine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Levocabastine.
Urethane
The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Levocabastine.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Levocabastine.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Levocabastine.
Venlafaxine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Levocabastine.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Levocabastine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Levocabastine.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Levocabastine.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Levocabastine.
Zolpidem
Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Levocabastine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Levocabastine.
Zotepine
The risk or severity of adverse effects can be increased when Zotepine is combined with Levocabastine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Levocabastine.
